Phytoselective therapy is a method of choice for the treatment of mastopathy in combination with premenstrual syndrome

Autor: O. V. Gryshchenko, V. V. Bobrytska

Publikováno v: Репродуктивная эндокринология, Vol 0, Iss 55, Pp 79-89 (2020)

Breast dishormonal diseases and premenstrual syndrome (PMS) have a common pathogenetic mechanism: hyperprolactinemia, decreased progesterone levels, thyroid dysfunction, increased cortisol including as a result of stress, dysphoric disorders. Purpos

Externí odkaz: https://doaj.org/article/72bc2e55714e4041ad70de45b480c86e

New patterns of menstrual disorders’ treatment – unification of the method

Autor: О. В. Грищенко, В. В. Бобрицкая

Publikováno v: Репродуктивная эндокринология, Vol 0, Iss 47, Pp 26-32 (2019)

Effective treatment of menstrual cycle disorders, elimination of polypragmasia, and unification of the method in various types of menstrual disorders is an important task of modern science and practice. The aim of the study was to optimize the treat

Externí odkaz: https://doaj.org/article/6340e9b0b6504efe8d9b2d2ec90f255c

Predictors of reproductive health disorders

Autor: Т. Ф. Татарчук

Publikováno v: Репродуктивная эндокринология, Iss 43, Pp 62-67 (2018)

«Bell» indicating a change in reproductive health is menstrual cycle disorders. 10–28% of the total number of endocrine gynecological diseases is menstrual cycle disorders, its clinical manifestations are absence of menstruation or rare or poor m

Externí odkaz: https://doaj.org/article/ba2c1f2129c54d71896db3af2481f5f3

Pathogenetic substantiation of advantages and duration of phytoselective therapy of the menstrual cycle disorders

Publikováno v: Репродуктивная эндокринология, Vol 0, Iss 48, Pp 13-21 (2019)

Определение оптимального препарата для лечения нарушений менструального цикла и длительности терапии является одной из актуальных со�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98f6dd162332045d1c5b8c42d681a3f2
https://doi.org/10.18370/2309-4117.2019.48.13-21

Phytoselective therapy is a method of choice for the treatment of mastopathy in combination with premenstrual syndrome

Autor: Gryshchenko, O. V., Bobrytska, V. V.

Publikováno v: Reproductive Endocrinology; № 55 (2020); 79-89
Репродуктивная эндокринология; № 55 (2020); 79-89
Репродуктивна ендокринологія; № 55 (2020); 79-89

Дисгормональные заболевания молочной железы (ДЗМЖ) и предменструальный синдром (ПМС) имеют общий патогенетический механизм: гиперпрола

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::1b1c944a840194b2debbfffc42f97938
http://reproduct-endo.com/article/view/218454